Article Information
History
- July 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Paula L. Hedley1,
- Steen Hoffmann2,
- Ulrik Lausten-Thomsen3,
- Marianne Voldstedlund4,
- Karsten Dalsgaard Bjerre4,
- Anders Hviid5,6,
- Lone Krebs7,8,
- Jørgen S. Jensen2 and
- Michael Christiansen1,9,*
- 1Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
- 2Department of Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark
- 3Department of Neonatology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
- 4Data integration and Analysis, Statens Serum Institut, Copenhagen, Denmark
- 5Department of Epidemiological Research, Statens Serum Institut, Copenhagen, Denmark
- 6Department of Drug Development and Clinical Pharmacology, Pharmacovigilance Research Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 7Department of Gynecology and Obstetrics, Copenhagen University Hospital, Amager and Hvidovre Hospital, Copenhagen, Denmark
- 8Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- 9Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark
- ↵*Correspondence
: Michael Christiansen, MD, FRCPath, Department for Congenital Disorders, Statens Serum Institut, Ph: +432683657 E-mail: mic{at}ssi.dk
Posted July 06, 2021.
A nationwide study of Chlamydia trachomatis infections in Denmark during the COVID-19 pandemic
